{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T23:55:15Z","timestamp":1771458915401,"version":"3.50.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaci-global.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology: Global"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jacig.2024.100294","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T17:53:58Z","timestamp":1719510838000},"page":"100294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Allergic bronchopulmonary aspergillosis as an initial manifestation of cystic fibrosis: Diagnostic and therapeutic implications in the era of CFTR modulators"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8864-2467","authenticated-orcid":false,"given":"Georgia","family":"Mitropoulou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zisis","family":"Balmpouzis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurelia","family":"Oberhansli-Wavre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvain","family":"Blanchon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Sauty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Koutsokera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacig.2024.100294_bib1","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/thx.2010.145862","article-title":"ABPA in adulthood: a CFTR-related disorder","volume":"66","author":"Lebecque","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.jacig.2024.100294_bib2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/02770900009055429","article-title":"Distribution and severity of bronchiectasis in allergic bronchopulmonary aspergillosis (ABPA)","volume":"37","author":"Mitchell","year":"2000","journal-title":"J Asthma"},{"key":"10.1016\/j.jacig.2024.100294_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/1744666X.2017.1232620","article-title":"Allergic bronchopulmonary aspergillosis in asthma","volume":"13","author":"Knutsen","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100294_bib4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1439-0507.2011.02130.x","article-title":"Link between CFTR mutations and ABPA: a systematic review and meta-analysis","volume":"55","author":"Agarwal","year":"2012","journal-title":"Mycoses"},{"key":"10.1016\/j.jacig.2024.100294_bib5","doi-asserted-by":"crossref","first-page":"5186","DOI":"10.4049\/jimmunol.177.8.5186","article-title":"Aspergillus fumigatus generates an enhanced Th2-biased immune response in mice with defective cystic fibrosis transmembrane conductance regulator","volume":"177","author":"Allard","year":"2006","journal-title":"J Immunol"},{"issue":"suppl\u00a03","key":"10.1016\/j.jacig.2024.100294_bib6","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1086\/376525","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation consensus conference","volume":"37","author":"Stevens","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jacig.2024.100294_bib7","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3389\/fcimb.2020.00372","article-title":"CFTR modulators dampen Aspergillus-induced reactive oxygen species production by cystic fibrosis phagocytes","volume":"10","author":"Currie","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jacig.2024.100294_bib8","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jcf.2022.09.007","article-title":"Advent of elexacaftor\/tezacaftor\/ivacaftor for cystic fibrosis treatment: what consequences on Aspergillus-related diseases? Preliminary insights","volume":"21","author":"Chesnay","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jacig.2024.100294_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1180826","article-title":"Proliferative activity of antigen-specific CD154+ T cells against bacterial and fungal respiratory pathogens in cystic fibrosis decreases after initiation of highly effective CFTR modulator therapy","volume":"14","author":"Eschenhagen","year":"2023","journal-title":"Front Pharmacol"}],"container-title":["Journal of Allergy and Clinical Immunology: Global"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829324000900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829324000900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T17:48:37Z","timestamp":1731347317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772829324000900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2772829324000900"],"URL":"https:\/\/doi.org\/10.1016\/j.jacig.2024.100294","relation":{},"ISSN":["2772-8293"],"issn-type":[{"value":"2772-8293","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allergic bronchopulmonary aspergillosis as an initial manifestation of cystic fibrosis: Diagnostic and therapeutic implications in the era of CFTR modulators","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology: Global","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacig.2024.100294","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}],"article-number":"100294"}}